Drugmaker Eli Lilly said it will spend $4.5 billion to build a new manufacturing research hub in Indiana, where it will develop new methods of producing complicated types of medicines. The new investment comes as Lilly and rival Novo Nordisk are ramping up manufacturing capacity due to skyrocketing demand for weight-loss drugs including Zepbound and Wegovy. The Lilly project announced Wednesday will allow it to develop new manufacturing techniques for experimental anti-obesity drugs and other medicines in its pipeline.
Twitter bio
Wall Street Journal @WSJ reporter - pharmaceuticals, medical devices, healthcare. [email protected]. Author of The Messenger